These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35679806)

  • 1. Amyloid, cerebrovascular disease, and neurodegeneration biomarkers are associated with cognitive trajectories in a racially and ethnically diverse, community-based sample.
    Lao PJ; Boehme AK; Morales C; Laing KK; Chesebro A; Igwe KC; Gutierrez J; Gu Y; Stern Y; Schupf N; Manly JJ; Mayeux R; Brickman AM
    Neurobiol Aging; 2022 Sep; 117():83-96. PubMed ID: 35679806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
    Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
    JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural MRI Predictors of Late-Life Cognition Differ Across African Americans, Hispanics, and Whites.
    Zahodne LB; Manly JJ; Narkhede A; Griffith EY; DeCarli C; Schupf NS; Mayeux R; Brickman AM
    Curr Alzheimer Res; 2015; 12(7):632-9. PubMed ID: 26027808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
    Chan CK; Pettigrew C; Soldan A; Zhu Y; Wang MC; Albert M; Rosenberg PB;
    J Alzheimers Dis; 2022; 86(3):1415-1426. PubMed ID: 35213370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Aging Among Racially and Ethnically Diverse Middle-Aged and Older Adults.
    Turney IC; Lao PJ; Rentería MA; Igwe KC; Berroa J; Rivera A; Benavides A; Morales CD; Rizvi B; Schupf N; Mayeux R; Manly JJ; Brickman AM
    JAMA Neurol; 2023 Jan; 80(1):73-81. PubMed ID: 36374494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.
    Yassi N; Hilal S; Xia Y; Lim YY; Watson R; Kuijf H; Fowler C; Yates P; Maruff P; Martins R; Ames D; Chen C; Rowe CC; Villemagne VL; Salvado O; Desmond PM; Masters CL
    J Alzheimers Dis; 2020; 73(3):897-907. PubMed ID: 31884485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan.
    Brickman AM; Schupf N; Manly JJ; Luchsinger JA; Andrews H; Tang MX; Reitz C; Small SA; Mayeux R; DeCarli C; Brown TR
    Arch Neurol; 2008 Aug; 65(8):1053-61. PubMed ID: 18695055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
    Han JW; Maillard P; Harvey D; Fletcher E; Martinez O; Johnson DK; Olichney JM; Farias ST; Villeneuve S; Jagust W; Mungas D; DeCarli C
    Neurology; 2020 Nov; 95(19):e2622-e2634. PubMed ID: 32732300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
    Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin ÅK; van Buchem MA; Oleksik A; Verbeek MM; Olde Rikkert M; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
    Alzheimers Res Ther; 2017 Dec; 9(1):101. PubMed ID: 29284531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex/gender differences in cognitive trajectories vary as a function of race/ethnicity.
    Avila JF; Vonk JMJ; Verney SP; Witkiewitz K; Arce Rentería M; Schupf N; Mayeux R; Manly JJ
    Alzheimers Dement; 2019 Dec; 15(12):1516-1523. PubMed ID: 31606366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of education and race on cognitive decline: An integrative study of generalizability versus study-specific results.
    Gross AL; Mungas DM; Crane PK; Gibbons LE; MacKay-Brandt A; Manly JJ; Mukherjee S; Romero H; Sachs B; Thomas M; Potter GG; Jones RN
    Psychol Aging; 2015 Dec; 30(4):863-880. PubMed ID: 26523693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Education differentially contributes to cognitive reserve across racial/ethnic groups.
    Avila JF; Rentería MA; Jones RN; Vonk JMJ; Turney I; Sol K; Seblova D; Arias F; Hill-Jarrett T; Levy SA; Meyer O; Racine AM; Tom SE; Melrose RJ; Deters K; Medina LD; Carrión CI; Díaz-Santos M; Byrd DR; Chesebro A; Colon J; Igwe KC; Maas B; Brickman AM; Schupf N; Mayeux R; Manly JJ
    Alzheimers Dement; 2021 Jan; 17(1):70-80. PubMed ID: 32827354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
    Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
    J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study.
    Hong YJ; Park JW; Lee SB; Kim SH; Kim Y; Ryu DW; Park KW; Yang DW
    Dement Geriatr Cogn Disord; 2021; 50(5):437-445. PubMed ID: 34736258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.
    Racine AM; Koscik RL; Berman SE; Nicholas CR; Clark LR; Okonkwo OC; Rowley HA; Asthana S; Bendlin BB; Blennow K; Zetterberg H; Gleason CE; Carlsson CM; Johnson SC
    Brain; 2016 Aug; 139(Pt 8):2261-74. PubMed ID: 27324877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
    Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
    Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.